Procter & Gamble Hygiene and Health Care Limited (PGHH.BO)
INR 14143.25
(-0.44%)
INR 14143.25
(-0.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.83 Billion INR | -9.03% |
| 2022 | 11.91 Billion INR | 26.06% |
| 2021 | 9.45 Billion INR | 2.89% |
| 2020 | 9.18 Billion INR | 36.97% |
| 2019 | 6.7 Billion INR | -5.29% |
| 2018 | 7.07 Billion INR | 14.22% |
| 2017 | 6.19 Billion INR | -2.23% |
| 2016 | 6.34 Billion INR | 23.2% |
| 2015 | 5.14 Billion INR | -14.61% |
| 2014 | 6.02 Billion INR | 19.34% |
| 2013 | 5.05 Billion INR | 13.75% |
| 2012 | 4.43 Billion INR | 10.58% |
| 2011 | 4.01 Billion INR | 44.92% |
| 2010 | 2.77 Billion INR | -7.65% |
| 2009 | 3 Billion INR | 41.8% |
| 2008 | 2.11 Billion INR | -2.59% |
| 2007 | 2.17 Billion INR | 32.5% |
| 2006 | 1.63 Billion INR | -3.53% |
| 2005 | 1.69 Billion INR | -35.98% |
| 2004 | 2.65 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 11.74 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 10.83 Billion INR | 0.0% |
| 2023 FY | 10.83 Billion INR | -9.03% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 11.91 Billion INR | 0.0% |
| 2022 FY | 11.91 Billion INR | 26.06% |
| 2022 Q2 | 11.15 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 11.26 Billion INR | 0.0% |
| 2021 Q4 | 9.45 Billion INR | 0.0% |
| 2021 FY | 9.45 Billion INR | 2.89% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 9.18 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 9.18 Billion INR | 36.97% |
| 2020 Q2 | 8.94 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 6.7 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 6.7 Billion INR | -5.29% |
| 2019 Q2 | 7.58 Billion INR | 0.0% |
| 2018 Q2 | 8.65 Billion INR | 0.0% |
| 2018 FY | 7.07 Billion INR | 14.22% |
| 2018 Q4 | 7.07 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q4 | 6.19 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 7.12 Billion INR | 0.0% |
| 2017 FY | 6.19 Billion INR | -2.23% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 6.34 Billion INR | 23.2% |
| 2016 Q4 | 6.34 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 5.85 Billion INR | 0.0% |
| 2015 Q2 | 5.95 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 5.14 Billion INR | -14.61% |
| 2015 Q4 | 5.14 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 4.8 Billion INR | 0.0% |
| 2014 FY | 6.02 Billion INR | 19.34% |
| 2014 Q4 | 6.02 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 5.05 Billion INR | 0.0% |
| 2013 FY | 5.05 Billion INR | 13.75% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 4.04 Billion INR | 0.0% |
| 2012 Q2 | 3.3 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 FY | 4.43 Billion INR | 10.58% |
| 2012 Q4 | 4.43 Billion INR | 0.0% |
| 2011 FY | 4.01 Billion INR | 44.92% |
| 2011 Q4 | 4.01 Billion INR | 0.0% |
| 2010 Q4 | 2.77 Billion INR | 0.0% |
| 2010 FY | 2.77 Billion INR | -7.65% |
| 2009 FY | 3 Billion INR | 41.8% |
| 2008 FY | 2.11 Billion INR | -2.59% |
| 2007 FY | 2.17 Billion INR | 32.5% |
| 2006 FY | 1.63 Billion INR | -3.53% |
| 2005 FY | 1.69 Billion INR | -35.98% |
| 2004 FY | 2.65 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -37887.241% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -885.359% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | -608.296% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 18.036% |
| Cupid Limited | 186.52 Million INR | -5709.914% |
| Dabur India Limited | 48.19 Billion INR | 77.515% |
| Emami Limited | 8.21 Billion INR | -31.839% |
| Gillette India Limited | 8.59 Billion INR | -26.088% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 81.624% |
| Hindustan Unilever Limited | 270.76 Billion INR | 95.998% |
| Hipolin Limited | 48.57 Million INR | -22210.749% |
| Honasa Consumer Limited | 5.36 Billion INR | -101.892% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -3888.502% |
| Jyothy Labs Limited | 5.9 Billion INR | -83.454% |
| Kaya Limited | 5.22 Billion INR | -107.511% |
| Marico Limited | 32.52 Billion INR | 66.676% |
| N.K Industries Limited | 22.4 Billion INR | 51.627% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -6509.176% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -5167.712% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -13416.008% |